Carregant...

p73 poses a barrier to malignant transformation by limiting anchorage-independent growth

p53 is known to prevent tumour formation by restricting the proliferation of damaged or oncogene-expressing cells. In contrast, how the p53 family member p73 suppresses tumour formation remains elusive. Using a step-wise transformation protocol for human cells, we show that, in premalignant stages,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Beitzinger, Michaela, Hofmann, Lars, Oswald, Claudia, Beinoraviciute-Kellner, Rasa, Sauer, Markus, Griesmann, Heidi, Bretz, Anne Catherine, Burek, Christof, Rosenwald, Andreas, Stiewe, Thorsten
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2008
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2265751/
https://ncbi.nlm.nih.gov/pubmed/18239687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emboj.2008.13
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!